Product identification
Medicine name:
Adrestan 30 mg hard capsules
Adrestan 30 mg hard capsules
Active substance and strength:
-
Trilostan30.00/milligram(s)1.00Capsule
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH02CA01
Authorisation number:
- VPA22622/003/002
Product identification number:
- 5ebe1ff8-3c7c-4a5a-b3ab-882b53be315f
Permanent identification number:
- 600000049146
Product details
Legal status of supply:
This information is not available for this product.
Pharmaceutical form:
-
Capsule, hard
Withdrawal period by route of administration:
-
Oral use
- Dog
Availability
Package description:
- Three PVC-PVdc/aluminium foil blister strips each containing 10 capsules.
Manufacturing sites for batch release:
- EN- Genera Inc.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.
Authorisation details
Authorisation status:
-
Valid
Authorisation procedure type:
-
Marketing Authorisation
Procedure number:
- IE/V/0503/002
Date of authorisation status change:
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Authorisation country:
-
Ireland
Responsible authority:
- Health Products Regulatory Authority
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation issued:
Reference member state:
-
Ireland
Concerned member states:
-
Belgium
-
France
-
Italy
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.
Additional information
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
First published:
Last updated:
How useful was this page?: